Jun 11, 2026 05:33AM

Jun 8, 2026 11:00AM

Jun 4, 2026 04:11AM

Apr 17, 2026 09:00PM

Mar 26, 2026 05:34AM

Mar 6, 2026 07:06AM

Mar 6, 2026 06:23AM Cantor Fitzgerald Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Neutral

Dec 31, 2025 11:05AM

Dec 11, 2025 04:01PM

Sep 23, 2025 05:12AM

Jul 24, 2025 06:33AM

Jul 8, 2025 03:14AM

Jul 1, 2025 06:24AM

Jun 18, 2025 11:31AM Zealand Pharma (ZEAL) announces positive topline results from Phase 1b study on dapiglutide

May 23, 2025 06:47AM

May 20, 2025 04:14AM

Mar 21, 2025 03:06AM

Mar 20, 2025 12:00PM

Feb 28, 2025 12:39AM

Jan 24, 2025 07:01AM

Dec 19, 2024 02:59PM Zealand Pharma (ZEAL) Receives FDA CRL for the glepaglutide New Drug Application

Oct 8, 2024 07:00PM

Oct 2, 2024 10:45AM

Sep 9, 2024 11:02AM

Aug 16, 2024 11:00AM

Jun 25, 2024 02:44PM

Jun 25, 2024 11:03AM

Jun 20, 2024 11:39AM Zealand Pharma (ZEAL) reports positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintide

404,873 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All